Will H. Cai represents issuers and global investment banks in US and Hong Kong capital market transactions. He also advises private equity funds and multinationals in their investments in Asia region.
Will Cai also works with Asian companies on their cross-border M&A activities. He has worked on over 70 successful IPOs in the US and Hong Kong capital markets in the last decade, with a focus on technology and new economy companies. Some of the deals include Legend Biotech and EHang Holdings’ IPOs on the Nasdaq.
Contact: wcai@cooley.com